A recent New York Times op-ed article highlights a proposal by Medicare to penalize physicians who order PSA testing “unnecessarily.” That proposal reflects the 2012 recommendation of the United States Preventive Services Task Force (USPSTF) against routine PSA testing on the grounds that biopsies and treatment for slow-growing cancers carry a higher risk of patient harm than those cancers.

Of course, those instances in which PSA testing helped detect aggressive—but treatable—prostate cancer, raise the question: if I don’t test and, subsequently, don’t detect a (potentially) treatable cancer, am I liable for malpractice?

Fortunately, physicians (and other primary care providers) are not expected to be perfect…at least not in terms of professional liability. They are expected to be careful, consistent, and aligned with the standard practice of their peers. That doesn’t exclude variation, as long as those decisions are fair and well documented. A missed or delayed cancer diagnosis does not suddenly condemn a physician who can demonstrate a pattern (“I have a conversation with all male patients over 50 about PSA testing; I share my recommendation and then we decide together.”) or rationalize a deviation from standard practice (“Mr. Jones, several times, expressed a grave concern about any invasive treatment. He had no family history of prostate cancer. We agreed to forgo PSA testing”).

Malpractice cases alleging a missed or delayed diagnosis of prostate cancer are relatively rare (six were filed against CRICO-insured providers from 2010–2014), and the issues raised in those cases are generally about care following PSA testing or other diagnostic processes (e.g., digital rectal exams, biopsies). This aligns with what we see in many “failure to diagnose” cases: ordered tests are not followed or results are not shared among providers (or with patients), care among multiple providers is not well coordinated, older complaints fall off the radar as new issues arise. Missteps like those do not align with anyone’s standard of care, and are much more apt to expose physicians (and others) to allegations of malpractice.

Related Blog Posts

    coffee and gavel

    CRICO Law Day: Celebrating 35 years of Protecting Providers

    Blog Post
    CRICO and its panel counsel convene annually at Law Day to look back at lessons learned and educate each other on advancements in our Harvard Medical community. This tradition ensures that we continue to nourish this invaluable partnership that protects the CRICO insured population.
    Balloon Sign at the Candello Summit for 2024

    Highlights of the Candello Summit

    Blog Post
    Find out what was discussed at the three-day Candello Member Summit and Coder Collaborative held in Boston this September. Topics ranged from Ambulatory Safety Nets, Patient Safety ROI to tools that reduce medmal risk.
    a person in the witness box at court

    Collaboration Among the MPL Defense Community is Needed to Counter the Aggressive Plaintiffs’ Bar

    Blog Post
    At the 4th Annual American Legal Connections (ALC) conference, more than 150 Medical Professional Liability (MPL) defense attorneys, claims leaders, reinsurers, and others gathered to discuss nuclear verdicts and high-value claims that have been sending mixed signals about MPL risk.

X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.
Confirm